Nature Chemical Biology 5, 100 - 107 (2009)
Published online: 4 January 2009 | doi:10.1038/nchembio.137
http://www.nature.com/nchembio/journal/v5/n2/abs/nchembio.137.html?lang=en



"Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer".

Baozhi Chen 1, 4, Michael E Dodge 1, 4, Wei Tang 1, Jianming Lu 2, Zhiqiang Ma 2, Chih-Wei Fan 1, Shuguang Wei 2, Wayne Hao 2, Jessica Kilgore 2, Noelle S Williams 2, Michael G Roth 2, James F Amatruda 3, Chuo Chen 2 and Lawrence Lum 1

1 Department of Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA.
2 Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA.
3 Departments of Pediatrics, Internal Medicine and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA.
4 These authors contributed equally to this work.

Correspondence to: Lawrence Lum 1     e-mail: lawrence.lum@utsouthwestern.edu




Abstract:

The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small molecules that target Wnt-mediated cellular responses. By screening a diverse synthetic chemical library, we have discovered two new classes of small molecules that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the production of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/beta-catenin pathway activity. With these small molecules, we establish a chemical genetic approach for studying Wnt pathway responses and stem cell function in adult tissue. We achieve transient, reversible suppression of Wnt/beta-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth. The signal transduction mechanisms shown here to be chemically tractable additionally contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chemical genetics and therapeutic goals.




Supplementary Information:

http://www.nature.com/nchembio/journal/v5/n2/suppinfo/nchembio.137_S1.html
...

Suppl. Figure 1: Identification of small molecule antagonists of the Wnt/b-catenin signal transduction pathway.




Suppl. Figure 2: IWR and IWP compounds specifically inhibit the Wnt/b-catenin pathway.


...




Additional References:

1. Frenster JH, and Hovsepian JA, “Models of embryonic gene-induced initiation and reversion of adult neoplasms”.

2. Frenster JH, and Hovsepian JA, "Models of  embryonic RNA initiating and reverting adult neoplasms".

3. Frenster JH, and Hovsepian JA, "Models of successive levels of resolution during individual gene transcription".




Further Topics in:  Euchromatin,  active DNA, and  RNA  ribo-regulators:

Links to Euchromatin Activator RNA Reviews:
Links to Euchromatin Activator RNA Research:
Links to Ultrastructural Probes of DNase I-Sensitive Sites:
Links to RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma Immuno-Pathology:
Links to Activated T-Lymphocyte Immunotherapy:
Links to Medical Systems Biology:
Links to Selective Gene Transcription:
Links to RNA-Induced Epigenetics:
Links to RNA-Induced Embryogenesis:
Links to RNA and Biological Causality:
Links to Reprogramming and Neoplasia:

A Brief History of Activator RNA:

"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA". (PowerPoint Presentation).




Top of Page - Euchromatin Network - Current Research - Forums - Other Sites - Future Events -


For Further Information and Feedback:
E-mail: frenster@euchromatin.net
Phone:  +1 650 367 6483
Fax:  +1 650 364 1773


euchromatin: "the most active portion of the genome within the cell nucleus".